Mitochondrial lipid dicarbonyls (mRCS) (mRCS)

Mitochondrial lipid dicarbonyls are highly reactive electrophilic molecules, such as malondialdehyde (MDA), 4-hydroxynonenal (4-HNE), and isolevuglandins, generated primarily through the non-enzymatic peroxidation of polyunsaturated fatty acids in mitochondrial membranes (PMID: 28435070). These species are central mediators of carbonyl stress, as they readily form covalent adducts with mitochondrial proteins, DNA, and phospholipids, leading to impaired bioenergetics and organelle damage (PMID: 23835161). Because mitochondria are major sites of reactive oxygen species (ROS) production, they are particularly susceptible to the accumulation of these dicarbonyls, which contributes to the pathogenesis of neurodegenerative diseases, diabetes, and cardiovascular disorders (PMID: 25681013). Therapeutic intervention involves the use of small-molecule scavengers, such as MitoGamide or 2-hydroxybenzylamine (2-HOBA), which are often conjugated to lipophilic cations like triphenylphosphonium (TPP) to ensure selective accumulation within the mitochondrial matrix (PMID: 27633331). These scavengers react with the dicarbonyls to form stable, non-toxic products, thereby preventing the carbonylation of critical mitochondrial components and preserving cellular function (PMID: 30104254).

Other names

Mitochondrial reactive dicarbonyl speciesLipid-derived dicarbonylsMitochondrial electrophilesMitochondrial dicarbonyls4-HydroxynonenalMalondialdehydeIsolevuglandins

Covalent sequestration and neutralization of reactive electrophilic dicarbonyl species to prevent protein and DNA adduct formation.